Olmesartan Medoxomil Tablet, Film Coated
Product Images NDC 71335-2380

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil (NDC 71335-2380). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (Lbl713352380)

Label (Lbl713352380)
Label for Olmesartan Medoxomil Tablets, USP 40 mg oral film-coated tablets. The unit-dose package contains 30 tablets and is repackaged by Bryant Ranch Prepack, Inc., Burbank, CA, with manufacturing by ScieGen Pharmaceuticals, Inc. The label includes storage instructions, pharmacist dosing reference URL, and child safety warnings. The NDC is 71335-2380-1.*
FDA Label Image

Structural Formula For Olmesartan Medoxomil (Olmesartan Medox Tabs Figure 1)

Structural Formula For Olmesartan Medoxomil (Olmesartan Medox Tabs Figure 1)
Chemical structure of olmesartan medoxomil shown as a 2D molecular diagram with labeled carbon, nitrogen, oxygen, and hydrogen groups, illustrating the arrangement of atoms in the active ingredient.*
FDA Label Image

Olmesartan Medoxomil Dose Response: Placebo-adjusted Reduction In Blood Pressure (mm Hg) (Olmesartan Medox Tabs Figure 2)

Olmesartan Medoxomil Dose Response: Placebo-adjusted Reduction In Blood Pressure (mm Hg) (Olmesartan Medox Tabs Figure 2)
A dose response curve chart depicting placebo-adjusted reduction in blood pressure (mmHg) for olmesartan medoxomil. The x-axis represents olmesartan medoxomil dose in mg (0 to 100 mg), the y-axis shows reduction in blood pressure in mmHg (0 to 14 mmHg). Two lines represent systolic and diastolic blood pressure reductions across increasing doses.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.